These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34796412)

  • 21. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study.
    Murai T; Ogino H; Manabe Y; Iwabuchi M; Okumura T; Matsushita Y; Tsuji Y; Suzuki H; Shibamoto Y
    Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):151-8. PubMed ID: 24332223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.
    Kohshi K; Yamamoto H; Nakahara A; Katoh T; Takagi M
    J Neurooncol; 2007 May; 82(3):297-303. PubMed ID: 17120158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
    Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
    Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
    Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
    J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
    Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
    World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.
    Kim DH; Schultheiss TE; Radany EH; Badie B; Pezner RD
    J Neurooncol; 2013 Oct; 115(1):37-43. PubMed ID: 23813230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.
    Ahmed KA; Freilich JM; Abuodeh Y; Figura N; Patel N; Sarangkasiri S; Chinnaiyan P; Yu HH; Etame AB; Rao NG
    J Neurooncol; 2014 May; 118(1):179-86. PubMed ID: 24604750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases.
    Eitz KA; Lo SS; Soliman H; Sahgal A; Theriault A; Pinkham MB; Foote MC; Song AJ; Shi W; Redmond KJ; Gui C; Kumar AMS; Machtay M; Meyer B; Combs SE
    JAMA Oncol; 2020 Dec; 6(12):1901-1909. PubMed ID: 33057566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
    Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
    Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
    Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
    Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis.
    Wijetunga A; Jayamanne D; Cook R; Parkinson J; Little N; Curtis J; Brown C; Back M
    J Clin Neurosci; 2020 Dec; 82(Pt A):155-161. PubMed ID: 33317725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
    Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy with a micro-multileaf collimator for brain metastasis in the primary motor cortex.
    Matsuda R; Hasegawa M; Tamamoto T; Ochi T; Miyasaka T; Inooka N; Hontsu S; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Nakase H
    J Radiat Res; 2022 Jan; 63(1):63-70. PubMed ID: 34927204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Maggi G; Riva M; Masci G; D'Agostino G; Finocchiaro G; Santoro A; Bello L; Scorsetti M
    PLoS One; 2016; 11(6):e0157869. PubMed ID: 27348860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
    Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of dose-response following hypofractionated stereotactic radiotherapy to the cavity after surgery for brain metastases.
    Garimall S; Shanker M; Johns E; Watkins T; Olson S; Huo M; Foote MC; Pinkham MB
    J Neurooncol; 2020 Jan; 146(2):357-362. PubMed ID: 31907796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.